Computational approaches to the rational design of nanoemulsions, polymeric micelles, and dendrimers for drug delivery

Nanomedicine: Nanotechnology, Biology, and Medicine

Volumn 8, Issue 1, 2012, Pages 20-36

  Huynh, Loan ^a   Neale, Chris ^b   Pomès, Régis ^b   Allen, Christine ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Drug formulations; Drug material compatibility; Molecular simulation; Nanoparticle; Theoretical prediction

Indexed keywords

ANALYTICAL PREDICTIONS; COMPUTATIONAL APPROACH; COST EFFICIENCY; DRUG DELIVERY SYSTEM; DRUG DELIVERY VEHICLES; DRUG FORMULATIONS; DRUG-MATERIAL COMPATIBILITY; FLORY-HUGGINS THEORY; MOLECULAR SIMULATIONS; NANO-EMULSIONS; PARTITION COEFFICIENT; POLYMERIC MICELLE; RATIONAL DESIGN; SOLUBILITY PARAMETERS; THEORETICAL APPROACH; THEORETICAL PREDICTION;

DENDRIMERS; DRUG DELIVERY; MICELLES; MOLECULAR STRUCTURE; OPTIMIZATION; SURFACE PROPERTIES;

NANOPARTICLES;

DENDRIMER; DOCETAXEL; DOXORUBICIN; GOLD NANOPARTICLE; PACLITAXEL; POLYMER;

CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; DRUG SOLUBILITY; HYDROPHOBICITY; LIPID BILAYER; LIPOPHILICITY; MICELLE; NANOEMULSION; PARTICLE SIZE; REVIEW;

DENDRIMERS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; EMULSIONS; HUMANS; LIPOSOMES; MICELLES; MODELS, THEORETICAL; NANOPARTICLES; NANOTECHNOLOGY; POLYMERS; SOLUBILITY; SURFACE PROPERTIES;

EID: 84855322653     PISSN: 15499634     EISSN: 15499642     Source Type: Journal    
DOI: 10.1016/j.nano.2011.05.006     Document Type: Review

References (113)

1. Lipinski C.A. Drug-like properties and the causes of poor solubility and poor permeability. J Pharmacol Toxicol Methods 2000, 44:235-249.
2. Koo O.M., Rubinstein I., Onyuksel H. Role of nanotechnology in targeted drug delivery and imaging: a concise review. Nanomed Nanotechnol Biol Med 2005, 1:193-212.
3. Whitesides G.M. The 'right' size in nanobiotechnology. Nat Biotechnol 2003, 21:1161-1165.
4. Ky K. Nanotechnology platforms and physiological challenges for cancer therapeutic. Nanomedicine 2007, 3:103-110.
5. Portney N.G., Ozkan M. Nano-oncology: drug delivery, imaging, and sensing. Anal Bioanal Chem 2006, 384:620-630.
6. Shah R.B., Khan M.A. Nanopharmaceuticals: challenges and regulatory perspective. Biotechnology: pharmaceutical aspects. Nanotechnology in drug delivery 2009, 633. Springer Science + Business Media, New York. M.M. de Villiers, P. Aramwit, G.S. Kwon (Eds.).
7. Constantinides P.P., Chaubal M.V., Shorr R. Advances in lipid nanodispersions for parenteral drug delivery and targeting. Adv Drug Del Rev 2008, 60:757-767.
8. Lundberg B.B., Risovic V., Ramaswamy M., Wasan K.M. A lipophilic paclitaxel derivative incorporated in a lipid emulsion for parenteral administration. J Control Rel 2003, 86:93-100.
9. Mulder W.J.M., Strijkers G.J., von Tilborg G.A.F., Griffioen A.W., Nicolay K. Lipid-based nanoparticles for contrast-enhanced MRI and molecular imaging. NMR Biomed 2006, 19:142-164.
10. Maas J., Kamm W., Hauck G. An integrated early formulation strategy - from hit evaluation to preclinical candidate profiling. Euro J Pharm Biopharm 2007, 66:1-10.
11. Gupta U., Agashe H.B., Asthana A., Jain N.K. Dendrimers: novel polymeric nanoarchitectures for solubility enhancement. Biomacromolecules 2006, 7:649-658.
12. Haddish-Berhane N., Rickus J.L., Haghighi K. The role of multiscale computational approaches for rational design of conventional and nanoparticle oral drug delivery systems. Int J Nanomed 2007, 2:315-331.
13. Nishiyama N., Kataoka K. Current state, achievements, and future prospects of polymeric micelles as nanocarriers for drug and gene delivery. Pharmacol Ther 2006, 112:630-648.
14. Gao Z., Lukyanov A.N., Singhal A., Torchilin V.P. Diacylpolymer micelles as nanocarriers for poorly soluble anticancer drugs. Nano Lett 2002, 2:979-982.
15. Carstens M.G., Jong P.H.J.L.F.d., Nostrum C.F.v., Kemmink J., Verrijk R., Leede L.G.J.d., et al. The effect of core composition in biodegradable oligomeric micelles as taxane formulations. Euro J Pharm Biopharm 2008, 68:596-606.
16. Jennings A., Tennant M. Discovery strategies in a pharmaceutical setting: the application of computational techniques. Expert Opin Drug Discov 2006, 1:709-721.
17. Kubinyi H. Combinatorial and computational approaches in structure-based drug design. Curr Opin Drug Discov Devel 1998, 16:16-27.
18. Chen H., Zhang Z., McNulty C., Olbert C., Yoon H.J., Lee J.W., et al. A high-throughput combinatorial approach for the discovery of a cremophor EL-free paclitaxel formulation. Pharm Res 2003, 20:1302-1308.
19. Xiang T.-X., Anderson B.D. Liposomal drug transport: a molecular perspective from molecular dynamics simulations in lipid bilayers. Adv Drug Del Rev 2006, 58:1357-1378.
20. Huynh L., Neale C., Pomès R., Allen C. Systematic design of unimolecular star copolymer micelles using molecular dynamics simulations. Soft Matter 2010, 6:5491-5501.
21. Huynh L., Grant J., Leroux J.-C., Delmas P., Allen C. Predicting the solubility of the anti-cancer agent docetaxel in small molecule excipients using computational methods. Pharm Res 2008, 25:147-157.
22. Huynh L., Leroux J.C., Allen C. Enhancement of docetaxel solubility via conjugation of formulation-compatible moieties. Org Biomol Chem 2009, 7:3437-3446.
23. Lee H., Larson R.G. Molecular dynamics study of the structure and interparticle interactions of polyethylene glycol-conjugated PAMAM dendrimers. J Phys Chem B 2009, 113:13202-13207.
24. Kholodovych V. Accurate predictions of cellular response using QSPR: a feasibility test of rational design of polymeric biomaterials. Polymer 2004, 45:7367-7379.
25. Patel S., Lavasanifar A., Choi P. Roles of nonpolar and polar intermolecular interactions in the improvement of the drug loading capacity of PEO-b-PCL with increasing PCL content for two hydrophobic cucurbitacin drugs. Biomacromolecules 2009, 10:2584-2591.
26. Lipinski C.A., Lombardo F., Dominy B.W., Feeney P.J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 2001, 46:3-26.
27. Jorgensen W.L., Duffy E.M. Prediction of drug solubility from structure. Adv Drug Del Rev 2002, 54:355-366.
28. Mannhold R., Rekker R.F. The hydrophobic fragmental constant approach for calculating log P in octanol/water and aliphatic hydrocarbon/water systems. Perspect Drug Discov Des 2000, 18:1-18.
29. Liu J., Xiao Y., Allen C. Polymer-drug compatibility: a guide to the development of delivery systems for the anticancer agent, ellipticine. J Pharm Sci 2003, 23:132-143.
30. Dwan'Isa J.-P.L., Rouxhet L., Préat V., Brewster M.E., Ariën A. Prediction of drug solubility in amphiphilic di-block copolymer micelles: the role of polymer-drug compatibility. Pharmazie 2007, 62:499-504.
31. Hildebrand J.H., Scott R.L. The solubility of nonelectrolytes 1950, Reinhold Publishing, New York, Chapter XVII. 3rd ed.
32. Allen M.P., Tildesley D.J. Molecular dynamics. Computer simulation of liquids 1987, 71-109. Clarendon Press Oxford, Oxford. M.P. Allen, D.J. Tildesley (Eds.).
33. Karplus M., McCammon J.A. Molecular dynamics simulations of biomolecules. Nat Struct Biol 2002, 9:646-652.
34. Ganazzoli F., Kuznetsov Y.A., Timoshenko E.G. Conformations of amphiphilic diblock star copolymers. Macromol Theory Simul 2001, 10:325-338.
35. Costache A.D., Sheihet L., Zaveri K., Knight D.D., Kohn J. Polymer-drug interactions in tyrosine-derived triblock copolymer nanospheres: a computational modeling approach. Mol Pharm 2009, 6:1620-1627.
36. Theodorou D.N. Hierarchical modelling of polymeric materials. Chem Eng Sci 2007, 62:5697-5714.
37. Lee H., de Vries A.H., Marrink S.-J., Pastor R.W. A coarse-grained model for polyethylene oxide and polyethylene glycol: conformation and hydrodynamics. J Phys Chem B 2009, 113:13186-13194.
38. Sutton D., Wang S., Nasongkla N., Gao J., Dormidontova E.E. Doxorubicin and β-lapachone release and interaction with micellar core materials: experiment and modeling. Exp Biol Med 2007, 232:1090-1099.
39. Lee H., Venable R.M., Mackerell A.D., Pastor R.W. Molecular dynamics studies of polyethylene oxide and polyethylene glycol: hydrodynamic radius and shape anisotropy. Biophys J 2008, 95:1590-1599.
40. Kuramochi H., Andoh Y., Yoshii N., Okazaki S. All-atom molecular dynamics study of a spherical micelle composed of N-acetylated poly(ethylene glycol)-poly(g-benzyl -glutamate) block copolymers: a potential carrier of drug delivery systems for cancer. J Phys Chem B 2009, 113:15181-15188.
41. Patel S., Lavasanifar A., Choi P. Molecular dynamics study of the encapsulation capability of a PCL-PEO based block copolymer for hydrophobic drugs with different spatial distributions of hydrogen bond donors and acceptors. Biomaterials 2010, 31:1780-1786.
42. Forrest M.L., Zhao A., Won C.Y., Malick A.W., Kwon G.S. Lipophilic prodrugs of Hsp90 inhibitor geldanamycin for nanoencapsulation in poly(ethylene glycol)-b-poly(e{open}-caprolactone) micelles. J Control Rel 2006, 116:139-149.
43. Buxton G.A., Clarke N. Drug diffusion from polymer core-shell nanoparticles. Soft Matter 2007, 3:1513-1517.
44. 19F relaxation NMR and molecular dynamics simulation. Langmuir 2008, 24:692-700.
45. Lee S.-J., Olsen B., Schlesinger P.H., Baker N.A. Characterization of perfluorooctylbromide-based nanoemulsion particles using atomistic molecular dynamics simulations. J Phys Chem B 2010, 114:10086-10096.
46. Faller B., Ertl P. Computational approaches to determine drug solubility. Adv Drug Del Rev 2007, 59:533-545.
47. Bhattachar S.N., Deschenes L.A., Wesley J.A. Solubility: it's not just for physical chemists. Drug Discov Today 2006, 11:1012-1018.
48. Hildebrand J.H. Solubility. J Am Chem Soc 1916, 38:1452-1473.
49. Hansen C.M. Hansen solubility parameters, a user's handbook 2007, CRC Press, Taylor & Francis Group, Boca Raton (Fla). 2nd ed.
50. Hancock B.C., York P., Rowe R.C. The use of solubility parameters in pharmaceutical dosage form design. Int J Pharm 1997, 148:1-21.
51. Li Y., Taulier N., Rauth A.M., Wu X.Y. Screening of lipid carriers and characterization of drug-polymer-lipid interactions for the rational design of polymer-lipid hybrid nanoparticles (PLN). Pharm Res 2006, 23:1877-1887.
52. Forster A., Hempenstall J., Tucker I., Rades T. Selection of excipients for melt extrusion with two poorly water-soluble drugs by solubility parameter calculation and thermal analysis. Int J Pharm 2001, 226:147-161.
53. van Krevelen D.W. Cohesive properties and solubility. Properties of polymer: their correlation with chemical structure; their numerical estimation and prediction from additive group contributions 1990, 189-224. Elsevier, New York. 3rd ed. D.W. van Krevelen (Ed.).
54. 3 microspheres by PEG coil template. Chem. Lett 2006, 35:1026-1027.
55. Flory P.J. Statistical thermodynamics of polymer solutions. Principles of polymer chemistry 1953, 495-540. Cornell University Press, Ithaca (N.Y.). 3rd ed. P.J. Flory (Ed.).
56. Flory P.J. Thermodynamics of high polymer solutions. J Chem Phys 1942, 10:51-61.
57. Huggins M.L. Theory of solutions of high polymers. J Am Chem Soc 1942, 64:1712-1719.
58. Fan C.F., Olafson B.D., Blanco M. Application of molecular simulation to derive phase diagrams of binary mixtures. Macromolecules 1992, 25:3667-3676.
59. Case F.H., Honeycutt J.D. Will my polymers mix? Applications of modeling to study miscibility, compatibility and formulation. TRIP 1994, 2:256.
60. Patel S., Lavasanifar A., Choi P. Application of molecular dynamics simulation to predict the compatability between water-insoluble drugs and self-associating poly(ethylene oxide)-b-poly(e{open}-caprolactone) block copolymers. Biomacromolecules 2008, 9:3014-3023.
61. Koch T., Strobl G.R. Concentration dependence of the Flory-Huggins interaction parameter of a polymer blend as determined by small-angle X-ray scattering experiments. J Polym Sci Pol Phys 1990, 28:343-353.
62. Mahmud A., Patel S., Molavi O., Choi P., Samuel J., Lavasanifar A. Self-associating poly(ethylene oxide)-b-poly(α-cholesteryl carboxylate-e{open}-caprolactone) block copolymer for the solubilization of STAT-3 inhibitor cucurbitacin I. Biomacromolecules 2009, 10:471-478.
63. Subashini M., Devarajan P.D., Ganeshchandra S.S., Doble M. Molecular dynamics simulation of drug uptake by polymer. J Mol Model 2010, 10.1007/s00894-010-0811-8.
64. van de Waterbeemd H., Carter R.E., Grassy G., Kubinyi H., Martin Y.C., Tute M.S., et al. Glossary of terms used in computational drug design (IUPAC Recommendations). Pure Appl Chem 1997, 69:1137-1152.
65. Rekker R.E., te Laak A.M., Mannhold R. On the reliability of calculated log P-values: Rekker, HanschLeo and Suzuki approach. Quant Struct Act Relat 1993, 12:152-157.
66. Nys G.G., Rekker R.F. The concept of hydrophobic fragmental constants (f-values). II. Extension of its applicability to the calculation of lipophilicities of aromatic and heteroaromatic structures. Eur J Med Chem 1974, 9:361-375.
67. Leo A.J. Calculating log Poct from structures. Chem Rev 1993, 93:1281-1306.
68. Devillers J., Domine D., Karcher W. Estimating n-octanol/water partition coefficients from the autocorrelation method. SAR QSAR Environ Res 1995, 3:301-306.
69. Ghose A.K., Pritchett A., Crippen G.M. Atomic physicochemical parameters for three dimensional structure directed quantitative structure-activity relationships III: Modeling hydrophobic interactions. J Comp Chem 1988, 9:80-90.
70. Lemal D.M. Perspective on fluorocarbon chemistry. J Org Chem 2004, 69:1-11.
71. Henneré G., Prognon P., Brion F., Nicolis I. Molecular dynamics study of a phospholipid monolayer at a water/triglyceride interface: towards lipid emulsion modelling. Chem Phys Lipids 2009, 157:86-93.
72. Pajula K., Taskinen M., Lehto V.P., Ketolainen J., Korhonen O. Predicting the formation and stability of amorphous small molecule binary mixtures from computationally determined Flory-Huggins interaction parameter and phase diagram. Mol Pharm 2010, 7:795-804.
73. Molavi O., Ma Z., Mahmud A., Alshamsan A., Samuel J., Lai R., et al. Polymeric micelles for the solubilization and delivery of STAT3 inhibitor cucurbitacins in solid tumors. Int J Pharm 2008, 347:118-127.
74. Forrest M.L., Yãñez J.A., Remsberg C.M., Ohgami Y., Kwon G.S., Davies N.M. Paclitaxel prodrugs with sustained release and high solubility in poly(ethylene glycol)-b-poly(e{open}-caprolactone) micelle nanocarriers: pharmacokinetic disposition, tolerability, and cytotoxicity. Pharm. Res 2007, 25:194-206.
75. Khalid M.N., Simard P., Hoarau D., Dragomir A., Leroux J.-C. Long circulating poly(ethylene glycol)-decorated lipid nanocapsules deliver docetaxel to solid tumors. Pharm Res 2006, 23:752-758.
76. Perron M.-È., Plourde F., Guérard S., Huynh L., Allen C., Leroux J.-C. An investigation on the use of tributyrin nanoemulsions for docetaxel delivery. J Drug Deliv Sci Tech 2008, 18:189-195.
77. Rossi J., Giasson S., Khalid M.N., Delmas P., Allen C., Leroux J.-C. Long-circulating poly(ethylene glycol)-coated emulsions to target solid tumors. Eur J Pharm Biopharm 2007, 67:329-338.
78. Debye P. The intrinsic viscosity of polymer solutions. J Chem Phys 1946, 14:636.
79. Flory P.J., Fisk J. Effect of volume exclusion on the dimensions of polymer chains. J Chem Phys 1966, 44:2243-2248.
80. Alexander S. Adsorption of chain molecules with a polar head. A scaling description. J Phys (Paris) 1977, 38:983-987.
81. deGennes P.G. Conformations of polymers attached to an interface. Macromolecules 1980, 13:1069-1075.
82. Wijmans C.M., Zhulina E.B. Polymer brushes at curved surfaces. Macromolecules 1993, 26:7214-7224.
83. Shang B.Z., Wang Z., Larson R.G. Molecular dynamics simulation of interactions between a sodium dodecyl sulfate micelle and a poly(ethylene oxide) polymer. J Phys Chem B 2008, 112:2888-2900.
84. van der Maarel J.R.C. Polymer conformation. Introduction to biopolymer physics 2007, World Scientific Co., Singapore, Chapter 2. J.R.C. van der Maarel (Ed.).
85. Kuga S. Pore-size distribution analysis of gel substances by size exclusion chromatography. J Chromatogr 1981, 206:449-461.
86. Daoud M., Cotton J.P. Star shaped polymers: a model for the conformation and its concentration dependence. J Phys (Paris) 1982, 43:531-538.
87. Devanand K., Selser J.C. Asymptotic behavior and long-range interactions in aqueous solution of poly(ethylene oxide). Macromolecules 1991, 24:5943-5947.
88. Shakeel F., Baboota S., Ahuja A., Ali J., Aqil M., Shafiq S. Nanoemulsions as vehicles for transdermal delivery of aceclofenac. AAPS PharmSciTech 2007, 8:E1-9.
89. Nagle J.F. Evidence of partial rotational order in gel phase DPPC. Biophys J 1993, 64:1110-1112.
90. Yokoyama H., Nakahara H., Nakagawa T., Shimono S., Sueishi K., Shibata O. Miscibility behavior of two-component monolayers at the air-water interface: perfluorocarboxylic acids and DMPE. J Colloid Interface Sci 2009, 337:191-200.
91. Bolen E.J., Holloway P.W. Quenching of tryptophan fluorescence by brominated phospholipid. Biochemistry 1990, 29:9638-9643.
92. Rauscher S., Neale C., Pomès R. Simulated tempering distributed replica sampling, virtual replica exchange, and other generalized-ensemble methods for conformational sampling. J Chem Theory Comput 2009, 5:2640-2662.
93. Kumar N., Ravikumar M.N.V., Domb A.J. Biodegradable block copolymers. Adv Drug Deliv Rev 2001, 53:23-44.
94. Allen C.J. The merging fields of polymer and lipid-based drug delivery. J Liposome Res 2003, 13:XI-XII. [commentary].
95. Lavik E., Langer R. Tissue engineering: current state and perspectives. Appl Microbiol Biotech 2004, 65:1-8.
96. Eberhart R.C., Su S.H., Nguyen K.T., Zilberman M., Tang L., Nelson K.D., et al. Bioresorbable polymeric stents: current status and future promise. J Biomat Sci Polym Edn 2003, 14:299-312.
97. Peng L.X., Ivetac A., Chaudhari A.S., Van S., Zhao G., Yu L., et al. Characterization of a clinical polymer-drug conjugate using multiscale modeling. Biopolymers 2010, 93:936-951.
98. Huang W., Wang W., Wang P., Tian Q., Zhang C., Wang C., et al. Glycyrrhetinic acid-modified poly(ethylene glycol)-b-poly(γ-benzyl l-glutamate) micelles for liver targeting therapy. Acta Biomater 2010, 6:3927-3935.
99. Juneja A., Numata J., Nilsson L., Knapp E.W. Merging implicit with explicit solvent simulations: polyethylene glycol. J Chem Theory Comput 2010, 6:1871-1883.
100. Jones M.-C., Ranger M. Leroux JC. pH-sensitive unimolecular polymeric micelles: synthesis and characterization of a novel drug carrier. Bioconjug Chem 2003, 14:774-781.
101. Schramm O.G., Pavlov G.M., von Erp H.P., Meier M.A.R., Hoogenboom R., Schubert U.S. A versatile approach to unimolecular water-soluble carriers: ATRP of PEGMA with hydrophobic star-shaped polymeric core molecules as an alternative for PEGylation. Macromolecules 2009, 42:1808-1816.
102. Xin J., Liu D., Zhong C. Multicompartment micelles from star and linear triblock copolymer blends. J Phys Chem B 2007, 111:13675-13682.
103. Crampton H.L., Simanek E.E. Dendrimers as drug delivery vehicles: non-covalent interactions of bioactive compounds with dendrimers. Polym Int 2007, 56:489-496.
104. Yang H., Morris J.J., Lopin S.T. Polyethylene glycol-polyamidoamine dendritic micelle as solubility enhancer and the effect of the length of polyethylene glycol arms on the solubility of pyrene in water. J Colloid Interface Sci 2004, 273:148-154.
105. Dreher M.R., Liu W.G., Michelich C.R., Dewhirst M.W., Yuan F., Chilkoti A. Tumor vascular permeability, accumulation, and penetration of macromolecular drug carriers. J Natl Cancer Inst 2006, 98:335-344.
106. Bogusz S., Venable R.M., Pastor R.W. Molecular dynamics simulations of octyl glucoside micelles: structural properties. J Phys Chem B 2000, 104:5462-5470.
107. Castner D.G., Ratner B.D. Biomedical surface science: foundations to frontiers. Surf Sci 2002, 500:25-60.
108. Metullio L., Ferrone M., Coslanich A., Fuchs S., Fermeglia M., Paneni M.S., et al. Polyamidoamine (yet not PAMAM) dendrimers as bioinspired materials for drug delivery: structure-activity relationships by molecular simulations. Biomacromolecules 2004, 5:1371-1378.
109. Chen H.-T., Neerman M.F., Parrish A.R., Simanek E.E. Cytotoxicity, hemolysis, and acute in vivo toxicity of dendrimers based on melamine, candidate vehicles for drug delivery. J Am Chem Soc 2004, 126:10044-10048.
110. Fuchs S., Kapp T., Otto H., Schöneberg T., Franke P., Gust R., et al. A surface-modified dendrimer set for potential application as drug delivery vehicles: synthesis, in vitro toxicity, and intracellular localization. Chem Eur J 2004, 10:1167-1192.
111. Geng Y., Dalhaimer P., Cai S., Tsai R., Tewari M., Minko T., et al. Shape effects of filaments versus spherical particles in flow and drug delivery. Nat. Nanotechnol 2007, 2:249-255.
112. Decuzzi P., Pasqualini R., Arap W., Ferrari M. Intravascular delivery of particulate systems: does geometry really matter?. Pharm Res 2008, 26:235-243.
113. Lin J., Zhang H., Chen Z., Zheng Y. Penetration of lipid membranes by gold nanoparticles: insights into cellular uptake, cytotoxicity, and their relationship. Nano 2010, 4:5421-5429.